Nearly 30–50% of PBC patients show positivity for MND (i.e., anti-sp100 reactivity) and RL/M (i.e., anti-gp210 reactivity), thus reflecting a low diagnostic sensitivity [9,11,12]. The gene discussed is SP100; the disease is primary biliary cholangitis.